These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15717414)

  • 1. CDC issues updated guidelines on use of antiretroviral drugs to prevent HIV infection after sexual, drug use, and accidental exposure.
    Indian J Med Sci; 2005 Jan; 59(1):47-8. PubMed ID: 15717414
    [No Abstract]   [Full Text] [Related]  

  • 2. CDC Releases Updated Guidelines for Postexposure Prophylaxis After Sexual, Injection Drug, or Other Nonoccupational Exposures to HIV.
    Goldschmidt RH
    Am Fam Physician; 2016 Sep; 94(5):392-3. PubMed ID: 27583430
    [No Abstract]   [Full Text] [Related]  

  • 3. Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):458. PubMed ID: 27149423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC issues HIV prevention fact sheets for injection drug use.
    AIDS Policy Law; 2002 Mar; 17(5):4. PubMed ID: 11924210
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV occupational exposure guidelines revised.
    Traynor K
    Am J Health Syst Pharm; 2005 Nov; 62(22):2332, 2334. PubMed ID: 16278316
    [No Abstract]   [Full Text] [Related]  

  • 6. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC gives communities prevention strategies. Centers for Disease Control and Prevention.
    AIDS Alert; 1999 Jun; 14(6):66. PubMed ID: 11366409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Sep; 47(RR-17):1-14. PubMed ID: 9763107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?
    Kuhn L; Susser I; Stein Z
    Lancet; 2011 Jul; 378(9787):285-7. PubMed ID: 21763941
    [No Abstract]   [Full Text] [Related]  

  • 10. New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B.
    Soriano V; Vispo E; Barreiro P
    AIDS; 2011 Apr; 25(7):1013-4. PubMed ID: 21487255
    [No Abstract]   [Full Text] [Related]  

  • 11. Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France.
    Rey D; Bendiane MK; Bouhnik AD; Almeda J; Moatti JP; Carrieri MP
    AIDS Care; 2008 May; 20(5):537-41. PubMed ID: 18484321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing HIV transmission in intravenous-drug users not in drug treatment--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Aug; 39(31):529, 535-8. PubMed ID: 2115973
    [No Abstract]   [Full Text] [Related]  

  • 13. Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
    Lurie P; Miller S; Hecht F; Chesney M; Lo B
    JAMA; 1998 Nov; 280(20):1769-73. PubMed ID: 9842953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the scope of HIV prevention for adolescents: beyond individual-level interventions.
    DiClemente RJ; Wingood GM
    J Adolesc Health; 2000 Jun; 26(6):377-8. PubMed ID: 10822177
    [No Abstract]   [Full Text] [Related]  

  • 15. NIH develops consensus statement on interventions to prevent HIV risk behaviors.
    Rose VL
    Am Fam Physician; 1997 Aug; 56(2):623-4. PubMed ID: 9262537
    [No Abstract]   [Full Text] [Related]  

  • 16. CDC takes a large tiger by the tail: how to handle post-exposure treatment. Centers for Disease Control and Prevention.
    AIDS Alert; 1997 Sep; 12(9):97-100. PubMed ID: 11364588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual behaviour among users of antiretroviral pre-exposure prophylaxis.
    Underhill K; Mayer KH
    Lancet Infect Dis; 2013 Dec; 13(12):996-7. PubMed ID: 24139638
    [No Abstract]   [Full Text] [Related]  

  • 18. PHS issues guidelines for treating occupational exposure to HIV. Public Health Service.
    NIAID AIDS Agenda; 1996 Sep; ():11. PubMed ID: 11363919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDC issues guidelines urging the use of PrEP for HIV prevention.
    AIDS Policy Law; 2014 Jul; 29(8):1, 4. PubMed ID: 25151679
    [No Abstract]   [Full Text] [Related]  

  • 20. CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
    AIDS Policy Law; 1997 Jun; 12(12):4. PubMed ID: 11364408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.